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T he slow but unremitting growth of pediatric audiology over the last five decades has culminated in the actuality 
of delivering services to the youngest and most vulnerable 
population. This makes preventive audiology a practicable 
and fundamental foray in current times. Early detection 
and intervention for hearing impaired infants has become a 
progressively imperative aspect of neonatal and infant care and 
has magnified the audiological scope of practice significantly, 
as a form of secondary prevention.[1] This change in scope of 
practice has produced a host of new challenges in the delivery 
of effective and reliable hearing care services to newborns and 
young infants. This has also resulted in large scale research 
initiatives that address the rising surge of questions regarding 
the improvement of methodologies for identification and 
intervention of hearing loss, most especially in developing 
countries.[2,3] One of the questions that the current study aims 
to explore is whether epidural anesthesia has any effect on the 
hearing screening results in newborns.
The process of identifying the section of population at the 
highest risk of hearing loss is an essential component of 
audiological practice and serves as the initial step toward 
delivering effective audiological services to the pediatric 
population.[4] The screening of children and infants for 
hearing loss is a steadily advancing process that has accelerated 
significantly over the past few years. Even though a number 
of different methods of detecting hearing loss were evaluated 
earlier, it was only during the 1990s that substantial progress 
was made in lowering the average age at which significant 
hearing loss was identified.[5] This delayed identification of 
hearing loss was predominantly due to a lack of methodical 
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ABSTRACT
Objective: The main aim was to establish if epidural anesthesia had an influence on new-born hearing screening 
results in newborns born via elective Cesarean section in healthy pregnancies. Specific objectives included 
determining screening results in a group of newborns born to mothers who had undergone epidural anesthesia 
during Cesarean section childbirth (experimental group); and comparing the findings with those of a group of 
newborns born to mothers who had undergone natural delivery without epidural anesthesia (comparison group); 
while establishing if the time of screening following delivery had any effect on the overall screening results. 
Materials and Methods: The above objectives were achieved through the use of a prospective quasi-experimental 
repeated measures design with a comparison group, where 40 newborns (20 in the experimental and 20 in the 
comparison group) were screened at three different times through transient otoacoustic emissions (TEOAEs) and 
automated auditory brainstem response (AABR) measures. All participants were screened while resting quietly in 
open bassinets in an empty new-born nursery. For both test measures, the results were recorded as either pass 
or refer. Data were analyzed through both descriptive and inferential statistics. Results: Findings indicated that 
hearing screening earlier than four hours after birth, for both the experimental and comparison groups yielded more 
false positive findings than testing conducted after 24 hours. An index of suspicion in relation to the influence of 
epidural anesthesia on Automated Auditory Brainstem Response (AABR), when conducted less than four hours 
after birth, was raised, as statistically significant findings (P<0.05) were obtained. Conclusions: The findings 
have implications for timing of screening where universal newborn hearing screening is being implemented.
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screening programs and the shortcomings of subjective 
behavioral screening methods. Fortunately, the emergence of 
a more accurate, noninvasive, and rapid means of screening 
hearing loss as well as more concerted and rigorous efforts by 
professional bodies, such as the Health Professions Council of 
South Africa,[6] has resulted in the prospect of screening prior 
to hospital discharge being urged and supported. 
As hearing loss cannot be promptly and effortlessly identifiable 
by routine clinical examinations such as behavioral observation,[7] 
screening with more objective electrophysiological measures 
such as otoacoustic emissions and auditory brainstem responses 
is advocated for the universal screening of all newborns and 
infants.[5,6] Universal new-born hearing screening programs 
are aimed at obtaining hearing screening results for every 
new-born at any time prior to discharge from the hospital.[8] 
This is believed to possibly be the major way forward to 
guarantee that early identification and early access to services, 
including amplification and individualized family-centered early 
communication intervention, ensues.[9] Early hearing detection 
through universal newborn screening has taken on exceptional 
reputation as being the best practice in child healthcare in the 
developed world;[10] and this highlights the value of ensuring that 
the methodologies employed are effective and accurate; and yield 
minimal false positive results in a time frame that is as early as 
possible. Therefore, it is vital to isolate and categorize factors 
that may influence the success or failure of new-born audiological 
screening programs, such as epidural anesthesia, in neonates born 
to mothers who undergo elective Cesarean section. 
False positive results are obtained when a condition is not 
present, but the test results indicate that it is present. For 
example, Owen et al,[11] document the high number of false 
positive results when OAEs are obtained in the first 24 hours 
after birth. Referral rates for OAEs are reported to be 5 – 20% 
when conducted earlier than 24 hours after birth and less than 
3% when conducted 24 to 48 hours after birth.[12] Differing 
results exist regarding the specificity of OAEs measured at 
various time intervals after birth. Korres, , et al,[13] report a 
high rate of screening OAE recordings after 24 hours. Research 
conducted by Levi et al,[14] indicates that OAEs can be measured 
reliably earlier than 48 hours after birth, while Pennsylvania 
Health Care Cost Containment Counsel[15] suggests that OAEs 
recorded after 48 hours are more reliable. 
Unfortunately, an early discharge from maternity wards may 
contribute to a significant increase in false positive results due to 
vernix in the ear canal.[16] Such reports underscore the need for 
establishing other conditions present early during the postnatal 
period; such as epidural anesthesia, which may increase the rate 
of false positive hearing screening findings. Stuart and Moretz[17] 
suppose that the presence of false positive results may be an 
important factor hindering the implementation of new-born 
hearing screening programs. False positive results are also 
assumed to incur a significant cost to screening procedures;[16] 
hence, the significance of the current study. According to Gorga 
et al.,[18] an efficient new-born audiological hearing screening 
program aims to identify newborns with a hearing loss in a cost-
effective manner, and incorporates tests that have a low false 
positive rate. Mehl and Thompson[19] assert that the expense of 
hearing screening programs also need to be deliberated in terms 
of the cost of special education and support programs. A delay 
in the diagnosis of a hearing loss leads to a cost to the general 
public, the child’s family, and the child with the hearing loss. 
This is thought to be particularly important considering the 
documented numbers of hearing impaired individuals. 
There is an increasing prevalence rate of hearing loss reported 
globally.[20] This increasing prevalence has resulted in the 
customary practice of universal new-born hearing screening 
in developed countries. Despite South Africa having a 
comparatively well-developed infrastructure compared to other 
regions in the Sub-Saharan Africa, new-born hearing screening 
programs are a long way from common practice. This may 
be due to the availability of very little contextual research on 
infant hearing screening. In addition, this lack of data and the 
increasing priority toward addressing the overwhelming burden 
of infectious diseases such as HIV / AIDS has raised obstacles 
in cultivating support, funding, and political activism for 
infant hearing screening.[20] Therefore, additional research on 
Early Hearing Detection and Intervention (EHDI) in a South 
African context is vital for the collation and development of 
appropriate and efficient neonatal hearing screening guidelines 
and protocols; hence, the current study.
With the documented prevalence of one to four in every 1000 
live births globally, hearing impairment is one of the most 
common congenital abnormalities in new-borns.[21] Globally, it 
is reported to be twice as prevalent as other neonatal conditions, 
screened for at birth.[22,23] The current literature suggests that 
globally, approximately six in every 1000 infants present with 
permanent hearing loss at birth or within the neonatal period.[24] 
This documented rise in the prevalence rate of hearing 
impairment worldwide correlates with that reported by the 
World Health Organization (WHO), which maintains that 
the estimate for incapacitating hearing loss has increased 
from 120 million to approximately 278 million in the decade 
between 1995 and 2005.[25] This increased prevalence is more in 
developing countries where it is reported that more than 90% of 
all infants with congenital or early-onset hearing loss reside.[24] 
In these developing countries, Olusanya and Newton[24] assert 
that environmental risks are more prevalent, and that early 
identification programs are exceptionally scarce. Moreover, this 
reported increased prevalence rate is reported to be even higher, 
if mild and unilateral hearing losses are also incorporated.[9]
Literature has identified universal new-born hearing screening 
as the recommended protocol for Early Hearing Detection and 
Intervention (EHDI), particularly in developed countries.[26] 
Factors influencing the implementation of universal new-born 
hearing screening in South African tertiary hospitals include: 
practicality, ergonomics and economics (cost effectiveness), and 
the availability of equipment and manpower.[26-28] 
If a South African prevalence estimate of 10% is used, an 
estimated 4.5 million individuals are present with sensorineural 
hearing loss.[28] This reportedly results in each audiologist being 
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required to serve a significantly larger number of patients when 
compared to their counterparts in developed countries. Most 
importantly, the majority of these audiologists operate within 
the private healthcare sector, where only a small minority 
of individuals who can afford these services can be seen.[28] 
Therefore, when matching population size with the number 
of qualified audiologists in South Africa, there is an apparent 
scarcity of manpower in the public healthcare sector.[28] This 
situation is far from being remedied, as formal training in 
the profession of audiology is also lacking in most tertiary 
institutions in developing countries.[27] 
In comparison to first world countries, the aforementioned 
factors may influence the ability of audiologists in South Africa 
to effectively implement universal new-born hearing screening 
on all infants, prior to hospital discharge. Therefore, the use 
of targeted screening in high-risk neonates, as well as a clear 
understanding of the influence that certain postnatal factors 
(such as epidural anesthesia ) may have on the implementation 
of early hearing screening measures may be more cogent. A need 
exists to determine the audiological findings in neonates born to 
mothers who have undergone epidural anesthesia during elective 
Cesarean sections. It is possible that anesthesia may depress 
the functioning of the auditory system, as also the integrity of 
the hearing screening, thereby causing false positive results.[29] 
Epidural anesthesia is a procedure that entails the injection 
of a substance outside the dura mater of the spinal cord, and 
this causes an autonomic and partial central nervous system 
blockade. It is commonly used for elective Cesarean section.[30] 
It has the advantage of allowing the mother to remain awake, 
minimizes the risk of maternal aspiration, and reduces drug 
effects on the new-born.[31] The long-term effects of epidural 
anesthesia, which are rare and minimal, have been well-
documented;[30] however, if or how the hearing abilities of 
new-born infants are affected by epidural anesthesia is not 
well established.
Some evidence of the influence of anesthesia on new-born 
infant’s hearing was reported as early as 1988 by Diaz et al,[32] 
examined the effects of maternal lidocaine hydrochloride 
anesthesia on the brainstem auditory evoked responses 
(BAERs) in neonates born by Cesarean delivery. In their study, 
the findings indicated the effect that maternal anesthesia had 
on the auditory brainstem response, with a significant delay 
noted in the central neural component of the BAER at 90 dB 
for the experimental group when compared to the control 
group. In another study by Bozynski et al,[33] the mean wave 
I-V intervals were prolonged when testing was conducted at 
less than four hours when compared to findings at 48 hours 
or longer; and these researchers concluded that changes in the 
serial auditory brainstem-evoked response tests occurred after 
maternal lignocaine epidural anesthesia in newborn infants, 
and that these changes correlated with the blood lignocaine 
concentrations. 
As many studies conducted in the United Kingdom, Israel, and a 
majority of the developed countries have already established the 
feasibility of hospital-based hearing screening programs despite 
early postnatal hospital discharge;[14,34] studies investigating 
improved methodological strategies need to be prioritized before 
the realization of effective and efficient low-cost universal new-
born hearing screening programs. This includes the appropriate 
timing of such programs in the postnatal period, to minimize 
false positive results, while ensuring early identification of 
neonatal hearing loss prior to hospital discharge.
Materials and Methods
Main aim
To establish if epidural anesthesia has an influence on new-born 
hearing screening results in newborns born via elective Cesarean 
section in healthy pregnancies.
Specific objectives
• To determine hearing screening results in a group 
of newborns born to mothers who had undergone 
epidural anesthesia during Cesarean section childbirth 
(experimental group);
• To compare hearing screening findings of the experimental 
group with those of newborns born to mothers who had 
undergone natural vaginal delivery without epidural 
anesthesia (comparison group);
• To establish if the time of the hearing screening following 
delivery has any effect on the screening results. 
Research design
This study employed a prospective quasi-experimental repeated 
measures design with a comparison group.[35,36] This design 
gave the researchers an opportunity to compare the findings of 




The sample comprised of 40 newborns that were born at the 
chosen private hospital in Johannesburg. The newborns were 
divided into 20 born to mothers who had chosen to undergo 
epidural anesthesia during Cesarean section childbirth 
(experimental group) and 20 born to mothers who had 
undergone a natural delivery without the use of epidural 
anesthesia (comparison group). 
Sampling strategy
A nonprobability sampling strategy, purposive sampling strategy 
was adopted. The participants were selected from a location 
convenient to the researchers, where the reported numbers of 
elective Cesarean section births were high. Participants meeting 
the inclusion criteria were identified through the Obstetrics and 
Gynecology Department at the research site and approached to 
participate in the study. 
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Inclusion criteria
Inclusion criteria for participation were: (i) mothers who had 
carried the newborns to their full gestational term; (ii) healthy 
pregnancy; (iii) maternal age less than 35; (iv) no identified 
risk factors, such as, a number of natural abortions, illness or 
condition/s that required admission to the Neonatal Intensive 
Care Unit, craniofacial anomalies, in-utero infections, family 
history of hearing loss; (v) Cesarean section with epidural 
anesthesia or normal vaginal delivery; and (vi) no epidural 
anesthesia during natural vaginal delivery.
Ethical considerations
Prior to the study being conducted, permission to conduct the 
study was secured from the Medical Human Research Ethics 
Committee — Protocol number M070307. Following ethical 
clearance, the researchers presented the research proposal to 
the Research Coordinator at the research site for approval 
to conduct the study. The Review Board at the research site 
reviewed and approved the study. Thereafter, the participants 
were invited to volunteer to participate in the study with the 
assistance of the nursing staff in the maternity ward. The 
following ethical practices were adhered to during this study:
• Permission to conduct the research was obtained from the 
gynecological specialist and pediatrician.
• Informed consent was obtained in writing from the mothers 
of the participants before hearing screening.
• The participants’ rights and worth were respected. 
• The voluntary nature of participation was made clear to 
the participants, and they were notified of their right to 
withdraw from the study at any point without any negative 
consequences.
• Confidentiality was ensured through the anonymity of 
participants and safe storage of information during and 
after the completion of the research. Research codes instead 
of participant identifying information were used.
• The researchers were sensitive toward maternal anxiety 
and when required, in-house counseling services were 
approached to assist.
• Participants who required further diagnostic testing were 
provided with both private and public health sector referral 
details, to ensure that the newborns received early intervention.
Data collection
Materials and procedures
All mothers in the study completed a questionnaire pertaining 
to the birth time, pregnancy, and birth and family medical 
history. Information obtained from this questionnaire and from 
the medical chart reviews allowed the researchers to ensure that 
the participants met the inclusion criteria and were without risk 
indicators for hearing loss as defined by the Health Professions 
Council of South Africa (HPCSA).[6] 
Screening measures that were recommended for newborn 
hearing screening were required to be physiological or objective 
in nature. These included transient evoked otoacoustic emissions 
(TEOAE), distortion product otoacoustic emissions (DPOAE), 
and automated auditory brainstem response (AABR).[27] 
TEOAEs were low intensity sounds originating from active 
amplification of the outer hair cells of the cochlear, whereas, 
DPOAEs were generated by two continuous pure tones 
presented simultaneously to the ear.[27,37] In contrast, the AABR 
was an electrical response to auditory stimuli and assessed the 
integrity and function of the eighth cranial nerve and auditory 
pathway. OAE and AABR testing modalities were considered 
to be complementary in nature; hence their combined use in 
the current study.[38]
All participating newborns were screened using automated 
TEOAEs (through the use of GSI AUDIO screener) followed 
by automated ABR (through the use of Maico MB11- MAICO 
Diagnostic) measures, while resting quietly in open bassinets 
in an empty new-born nursery. Although both these measures 
did not require testing to be conducted in a soundproof 
environment, as they possessed advanced digital signal 
processing that reduced the effect of ambient noise; the ambient 
noise levels were monitored through the use of a sound level 
meter during data collection, to ensure that the findings were 
valid and reliable and were not negatively influenced by noise. 
Nursing and sanitary staff were informed about the importance 
of a quiet environment to obtain accurate results.[18] Every 
effort was made to minimize physiological noise, by screening 
newborns when they were resting or immediately after feeding.[39] 
For both test measures, the results were recorded as either pass 
or refer for each participant at each testing session.
Data analysis
Pass / refer criteria for the analysis of TEOAE and AABR results 
was adopted. Due to the reported high ambient noise levels 
in a hospital,[37,40] which primarily affected low frequencies, 
250 Hertz (Hz) and 500 Hz were not included within the pass 
/ refer criteria. Gorga et al,[41] reported noise levels to affect 1 
kHz as well. 
Following consultation with a statistician, data were analyzed 
through both descriptive and inferential statistics, utilizing the 
statistical computer program SPSS. Inferential quantitative 
analyses of the audiological results were performed using 
inferential statistical methods, which included the t-test and 
Fishers Exact test due to their precision in showing relationships 
in sample sizes below 30.[42] The p-value (0.05) was selected to 
test the hypothesis with P<0.05 indicating rejection of the null 
hypothesis. The first null hypothesis for the current study was 
that epidural anesthesia did not have an effect on the hearing 
screening results of newborns, while its alternate hypothesis 
was that epidural anesthesia did have an effect. The second 
null hypothesis was that the time of testing did not have an 
effect on the results, while its alternate hypothesizes an effect.
Reliability and validity
The following measures were adopted to improve the reliability 
and validity of this study:
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Ambient noise levels were minimized and monitored to 
ensure accuracy of the results[18] and the physiological noise 
was minimized by only screening the infants when they were 
resting or immediately after feeding. Furthermore, for TEOAE 
screening, frequencies below 1 kHz were excluded from the 
analysis due to these frequencies being most affected by 
acoustic ambient noise, and external and internal artifacts.The 
audiological equipment used during the study had undergone 
the annual calibration prior to data collection, as per the 
manufacturer’s guidelines, and the biological calibration of 
the instruments was also performed prior to each testing 
session. Test administration and control of patient variables 
was consistent throughout the data collection time, to ensure 
reliability.[43]
Results and Discussion
Hearing screening results for the experimental group are 
depicted in Table 1. These findings indicate that a large majority 
(90%) of the newborns obtained refer results for TEOAEs at 
sessions 1 and 2 for the experimental group, while 40% obtained 
the refer findings at session 1 for the AABR.
The aforementioned results for session 1, although consistent 
with some previous reports of epidural anesthesia causing 
delayed latencies on the ABR should be interpreted with caution 
as the presence of vernix in the neonates could have had an 
additional influence on the AABR. Nonetheless, the fact that 
vernix could have also had a similar influence on the AABR 
in the comparison group, but did not, raises a strong index of 
suspicion about the role of epidural anesthesia, which was the 
only differentiating factor between the two groups. Of particular 
interest is the significant improvement in pass AABR screening 
results at sessions 2 and 3; possibly indicating that the effects 
of the anesthesia may have worn off by then. The same cannot 
be said for the OAE screening results, which seemed to remain 
fairly the same at sessions 1 and 2 for both groups; with clear 
significant changes at session 3. The TEOAE findings confirm 
documented evidence that OAE screening is more reliable 24 
hours after birth, due to vernix. 
Comparison of hearing screening findings of the 
experimental group with the comparison group
Overall, as depicted in Table 1 and Figure 1, a large majority of 
newborns in both groups obtained refer TEOAE findings at the 
earlier testing sessions. The TEOAE hearing screening findings 
of both groups only changed when screening was conducted 
after 24 hours (at discharge). The AABR findings indicated a 
higher (40% at session 1) refer rate in the experimental group 
when compared to the 10% in the comparison group. The AABR 
findings positively changed with all newborns who had obtained 
refer results at session 1 passing at sessions 2 and 3.
These findings may indicate that even though the effective 
use of OAEs and AABR as screening measures has been well 
established, it is important to establish factors that may 
influence the reliability of these measures. In the current study, 
epidural anesthesia seems to have had an influence with regard 
to increasing false positive findings when testing was conducted 
earlier than four hours after birth.
Establishing if the time of hearing screening following 
delivery has any effect on the screening results
The p-values of 0.00014 for a two-sided exact significance and 
0.00007 for a one-sided exact significance were found when 
examining if time of screening following delivery had any effect 
on the results. These values reject the null hypothesis (P<0.05), 
hence indicating that time of testing did have an effect on the 
screening results in the current study.
From the results obtained, it can be concluded that TEOAE 
testing earlier than four hours after birth, as well as between 
four and six hours after birth is unfavorable. This was 
postulated to be possibly due to the vernix present in the 
external auditory canal at such times. According to Korres 
et al,[13] and the Pennsylvania Health Care Cost Containment 
Counsel,[15] TEOAEs are viable tools during new-born hearing 
screening between 24 and 48 hours after birth, because at that 
time the external auditory canal would be free of vernix. An 
index of suspicion about the influence of epidural anesthesia 
was raised.
Conclusions
Despite the fact that the sample size for the current study was 
small; and therefore limited the generalizability of the results, 
findings from the current study have significant implications 
for the implementation of universal new-born hearing screening 
Table 1: Hearing screening results in the experimental and 
comparison group at the two testing sessions
Screening session  
and measure
Experimental group  
(n = 20)
Comparison group  
(n = 20)
Pass Refer Pass Refer
Session 1 TEOAEs 10% 90% 20% 80%
Session 1 AABR 60% 40% 90% 10%
Session 2 TEOAEs 10% 90% 20% 80%
Session 2 AABR 100% 0% 100% 0%
Session 3 TEOAEs 100% 0% 100% 0%
Session 3 AABR 100% 0% 100% 0%
AABR: P = 0.00001 (< 0.05). The P value [P = 0.00001 (< 0.05)] 
rejected the first null hypothesis, thus confirming that epidural anesthesia 
did have an effect on the AABR hearing screening results of newborns in 
the current study
Figure 1: Comparing the experimental and comparison results
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programs; particularly in developing countries, where allocation 
of resources is driven by priorities such as management of 
infectious conditions such as the HIV / AIDS pandemic. 
Knowing where and when to focus the available resources for 
the best and effective EHDI programs would not only improve 
service delivery; but may improve access by the general South 
African population to the services of audiologists; which are 
currently scarce, particularly in the public healthcare sector. 
From the current findings, evidence points to the reliability 
of performing hearing screening with AABR on the day of 
delivery, as long as that happens four hours following the birth, 
in newborns where anesthesia was used during delivery. The 
timing of universal hearing screening, especially in babies born 
with epidural anesthesia, is important, as the use of epidural 
anesthesia could lead to increased false positive results, which 
may therefore cause undue maternal anxiety. The use of OAEs 
seems to be significantly influenced by vernix in the first 
few hours following birth, highlighting the need for ensuring 
that fluids in the external auditory canal are actively cleared 
before reliable use of OAEs can be implemented as a screening 
measure before 24 hours. Findings from the current study have 
particular relevance in developing countries such as South 
Africa, where women attending state hospitals’ maternity wards 
are discharged with their babies a few hours after giving birth. 
The current study should be replicated within a larger sample 
size with diagnostic ABR and OAEs, where findings will not be 
restricted to pass or refer; but would provide specific findings 
about the site and degree of the influence of anesthesia on the 
auditory pathway.
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